Global Antacid Market Growth 2023-2029

Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.

LPI (LP Information)' newest research report, the “Antacid Industry Forecast” looks at past sales and reviews total world Antacid sales in 2022, providing a comprehensive analysis by region and market sector of projected Antacid sales for 2023 through 2029. With Antacid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antacid industry.

This Insight Report provides a comprehensive analysis of the global Antacid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antacid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Antacid market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antacid and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antacid.

The global Antacid market size is projected to grow from US$ 6083.7 million in 2022 to US$ 7700.2 million in 2029; it is expected to grow at a CAGR of 7700.2 from 2023 to 2029.

Global Antacid key players include CONBA, Bayer, Xiuzheng Pharma, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share over 35%, followed by Europe, and North America, both have a share about 55 percent. 
In terms of product, Proton Pump Inhibitor is the largest segment, with a share over 50%. And in terms of application, the largest application is OTC Drug, followed by Rx Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Antacid market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Proton Pump Inhibitor
    H2 Antagonist
    Acid Neutralizers

Segmentation by application
    OTC Drug
    Rx Drug

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    AstraZeneca
    Takeda Pharmaceutical
    Pfizer
    Reckitt Benckiser
    Bayer
    Procter＆Gamble
    GlaxoSmithKline
    Johnson＆Johnson
    CONBA
    Xiuzheng Pharma
    Sanofi
    Bausch Health
    CR SANJIU
    Reddy's Laboratories

Key Questions Addressed in this Report
What is the 10-year outlook for the global Antacid market?
What factors are driving Antacid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antacid market opportunities vary by end market size?
How does Antacid break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

List of Tables
    Table 1. Antacid Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Table 2. Antacid Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
    Table 3. Major Players of Proton Pump Inhibitor
    Table 4. Major Players of H2 Antagonist
    Table 5. Major Players of Acid Neutralizers
    Table 6. Global Antacid Sales by Type (2018-2023) & (M Units)
    Table 7. Global Antacid Sales Market Share by Type (2018-2023)
    Table 8. Global Antacid Revenue by Type (2018-2023) & ($ million)
    Table 9. Global Antacid Revenue Market Share by Type (2018-2023)
    Table 10. Global Antacid Sale Price by Type (2018-2023) & (USD/Unit)
    Table 11. Global Antacid Sales by Application (2018-2023) & (M Units)
    Table 12. Global Antacid Sales Market Share by Application (2018-2023)
    Table 13. Global Antacid Revenue by Application (2018-2023)
    Table 14. Global Antacid Revenue Market Share by Application (2018-2023)
    Table 15. Global Antacid Sale Price by Application (2018-2023) & (USD/Unit)
    Table 16. Global Antacid Sales by Company (2018-2023) & (M Units)
    Table 17. Global Antacid Sales Market Share by Company (2018-2023)
    Table 18. Global Antacid Revenue by Company (2018-2023) ($ Millions)
    Table 19. Global Antacid Revenue Market Share by Company (2018-2023)
    Table 20. Global Antacid Sale Price by Company (2018-2023) & (USD/Unit)
    Table 21. Key Manufacturers Antacid Producing Area Distribution and Sales Area
    Table 22. Players Antacid Products Offered
    Table 23. Antacid Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global Antacid Sales by Geographic Region (2018-2023) & (M Units)
    Table 27. Global Antacid Sales Market Share Geographic Region (2018-2023)
    Table 28. Global Antacid Revenue by Geographic Region (2018-2023) & ($ millions)
    Table 29. Global Antacid Revenue Market Share by Geographic Region (2018-2023)
    Table 30. Global Antacid Sales by Country/Region (2018-2023) & (M Units)
    Table 31. Global Antacid Sales Market Share by Country/Region (2018-2023)
    Table 32. Global Antacid Revenue by Country/Region (2018-2023) & ($ millions)
    Table 33. Global Antacid Revenue Market Share by Country/Region (2018-2023)
    Table 34. Americas Antacid Sales by Country (2018-2023) & (M Units)
    Table 35. Americas Antacid Sales Market Share by Country (2018-2023)
    Table 36. Americas Antacid Revenue by Country (2018-2023) & ($ Millions)
    Table 37. Americas Antacid Revenue Market Share by Country (2018-2023)
    Table 38. Americas Antacid Sales by Type (2018-2023) & (M Units)
    Table 39. Americas Antacid Sales by Application (2018-2023) & (M Units)
    Table 40. APAC Antacid Sales by Region (2018-2023) & (M Units)
    Table 41. APAC Antacid Sales Market Share by Region (2018-2023)
    Table 42. APAC Antacid Revenue by Region (2018-2023) & ($ Millions)
    Table 43. APAC Antacid Revenue Market Share by Region (2018-2023)
    Table 44. APAC Antacid Sales by Type (2018-2023) & (M Units)
    Table 45. APAC Antacid Sales by Application (2018-2023) & (M Units)
    Table 46. Europe Antacid Sales by Country (2018-2023) & (M Units)
    Table 47. Europe Antacid Sales Market Share by Country (2018-2023)
    Table 48. Europe Antacid Revenue by Country (2018-2023) & ($ Millions)
    Table 49. Europe Antacid Revenue Market Share by Country (2018-2023)
    Table 50. Europe Antacid Sales by Type (2018-2023) & (M Units)
    Table 51. Europe Antacid Sales by Application (2018-2023) & (M Units)
    Table 52. Middle East & Africa Antacid Sales by Country (2018-2023) & (M Units)
    Table 53. Middle East & Africa Antacid Sales Market Share by Country (2018-2023)
    Table 54. Middle East & Africa Antacid Revenue by Country (2018-2023) & ($ Millions)
    Table 55. Middle East & Africa Antacid Revenue Market Share by Country (2018-2023)
    Table 56. Middle East & Africa Antacid Sales by Type (2018-2023) & (M Units)
    Table 57. Middle East & Africa Antacid Sales by Application (2018-2023) & (M Units)
    Table 58. Key Market Drivers & Growth Opportunities of Antacid
    Table 59. Key Market Challenges & Risks of Antacid
    Table 60. Key Industry Trends of Antacid
    Table 61. Antacid Raw Material
    Table 62. Key Suppliers of Raw Materials
    Table 63. Antacid Distributors List
    Table 64. Antacid Customer List
    Table 65. Global Antacid Sales Forecast by Region (2024-2029) & (M Units)
    Table 66. Global Antacid Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 67. Americas Antacid Sales Forecast by Country (2024-2029) & (M Units)
    Table 68. Americas Antacid Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 69. APAC Antacid Sales Forecast by Region (2024-2029) & (M Units)
    Table 70. APAC Antacid Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 71. Europe Antacid Sales Forecast by Country (2024-2029) & (M Units)
    Table 72. Europe Antacid Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 73. Middle East & Africa Antacid Sales Forecast by Country (2024-2029) & (M Units)
    Table 74. Middle East & Africa Antacid Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 75. Global Antacid Sales Forecast by Type (2024-2029) & (M Units)
    Table 76. Global Antacid Revenue Forecast by Type (2024-2029) & ($ Millions)
    Table 77. Global Antacid Sales Forecast by Application (2024-2029) & (M Units)
    Table 78. Global Antacid Revenue Forecast by Application (2024-2029) & ($ Millions)
    Table 79. AstraZeneca Basic Information, Antacid Manufacturing Base, Sales Area and Its Competitors
    Table 80. AstraZeneca Antacid Product Portfolios and Specifications
    Table 81. AstraZeneca Antacid Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 82. AstraZeneca Main Business
    Table 83. AstraZeneca Latest Developments
    Table 84. Takeda Pharmaceutical Basic Information, Antacid Manufacturing Base, Sales Area and Its Competitors
    Table 85. Takeda Pharmaceutical Antacid Product Portfolios and Specifications
    Table 86. Takeda Pharmaceutical Antacid Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 87. Takeda Pharmaceutical Main Business
    Table 88. Takeda Pharmaceutical Latest Developments
    Table 89. Pfizer Basic Information, Antacid Manufacturing Base, Sales Area and Its Competitors
    Table 90. Pfizer Antacid Product Portfolios and Specifications
    Table 91. Pfizer Antacid Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 92. Pfizer Main Business
    Table 93. Pfizer Latest Developments
    Table 94. Reckitt Benckiser Basic Information, Antacid Manufacturing Base, Sales Area and Its Competitors
    Table 95. Reckitt Benckiser Antacid Product Portfolios and Specifications
    Table 96. Reckitt Benckiser Antacid Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 97. Reckitt Benckiser Main Business
    Table 98. Reckitt Benckiser Latest Developments
    Table 99. Bayer Basic Information, Antacid Manufacturing Base, Sales Area and Its Competitors
    Table 100. Bayer Antacid Product Portfolios and Specifications
    Table 101. Bayer Antacid Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 102. Bayer Main Business
    Table 103. Bayer Latest Developments
    Table 104. Procter＆Gamble Basic Information, Antacid Manufacturing Base, Sales Area and Its Competitors
    Table 105. Procter＆Gamble Antacid Product Portfolios and Specifications
    Table 106. Procter＆Gamble Antacid Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 107. Procter＆Gamble Main Business
    Table 108. Procter＆Gamble Latest Developments
    Table 109. GlaxoSmithKline Basic Information, Antacid Manufacturing Base, Sales Area and Its Competitors
    Table 110. GlaxoSmithKline Antacid Product Portfolios and Specifications
    Table 111. GlaxoSmithKline Antacid Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 112. GlaxoSmithKline Main Business
    Table 113. GlaxoSmithKline Latest Developments
    Table 114. Johnson＆Johnson Basic Information, Antacid Manufacturing Base, Sales Area and Its Competitors
    Table 115. Johnson＆Johnson Antacid Product Portfolios and Specifications
    Table 116. Johnson＆Johnson Antacid Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 117. Johnson＆Johnson Main Business
    Table 118. Johnson＆Johnson Latest Developments
    Table 119. CONBA Basic Information, Antacid Manufacturing Base, Sales Area and Its Competitors
    Table 120. CONBA Antacid Product Portfolios and Specifications
    Table 121. CONBA Antacid Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 122. CONBA Main Business
    Table 123. CONBA Latest Developments
    Table 124. Xiuzheng Pharma Basic Information, Antacid Manufacturing Base, Sales Area and Its Competitors
    Table 125. Xiuzheng Pharma Antacid Product Portfolios and Specifications
    Table 126. Xiuzheng Pharma Antacid Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 127. Xiuzheng Pharma Main Business
    Table 128. Xiuzheng Pharma Latest Developments
    Table 129. Sanofi Basic Information, Antacid Manufacturing Base, Sales Area and Its Competitors
    Table 130. Sanofi Antacid Product Portfolios and Specifications
    Table 131. Sanofi Antacid Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 132. Sanofi Main Business
    Table 133. Sanofi Latest Developments
    Table 134. Bausch Health Basic Information, Antacid Manufacturing Base, Sales Area and Its Competitors
    Table 135. Bausch Health Antacid Product Portfolios and Specifications
    Table 136. Bausch Health Antacid Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 137. Bausch Health Main Business
    Table 138. Bausch Health Latest Developments
    Table 139. CR SANJIU Basic Information, Antacid Manufacturing Base, Sales Area and Its Competitors
    Table 140. CR SANJIU Antacid Product Portfolios and Specifications
    Table 141. CR SANJIU Antacid Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 142. CR SANJIU Main Business
    Table 143. CR SANJIU Latest Developments
    Table 144. Reddy's Laboratories Basic Information, Antacid Manufacturing Base, Sales Area and Its Competitors
    Table 145. Reddy's Laboratories Antacid Product Portfolios and Specifications
    Table 146. Reddy's Laboratories Antacid Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 147. Reddy's Laboratories Main Business
    Table 148. Reddy's Laboratories Latest Developments
List of Figures
    Figure 1. Picture of Antacid
    Figure 2. Antacid Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Antacid Sales Growth Rate 2018-2029 (M Units)
    Figure 7. Global Antacid Revenue Growth Rate 2018-2029 ($ Millions)
    Figure 8. Antacid Sales by Region (2018, 2022 & 2029) & ($ Millions)
    Figure 9. Product Picture of Proton Pump Inhibitor
    Figure 10. Product Picture of H2 Antagonist
    Figure 11. Product Picture of Acid Neutralizers
    Figure 12. Global Antacid Sales Market Share by Type in 2022
    Figure 13. Global Antacid Revenue Market Share by Type (2018-2023)
    Figure 14. Antacid Consumed in OTC Drug
    Figure 15. Global Antacid Market: OTC Drug (2018-2023) & (M Units)
    Figure 16. Antacid Consumed in Rx Drug
    Figure 17. Global Antacid Market: Rx Drug (2018-2023) & (M Units)
    Figure 18. Global Antacid Sales Market Share by Application (2022)
    Figure 19. Global Antacid Revenue Market Share by Application in 2022
    Figure 20. Antacid Sales Market by Company in 2022 (M Units)
    Figure 21. Global Antacid Sales Market Share by Company in 2022
    Figure 22. Antacid Revenue Market by Company in 2022 ($ Million)
    Figure 23. Global Antacid Revenue Market Share by Company in 2022
    Figure 24. Global Antacid Sales Market Share by Geographic Region (2018-2023)
    Figure 25. Global Antacid Revenue Market Share by Geographic Region in 2022
    Figure 26. Americas Antacid Sales 2018-2023 (M Units)
    Figure 27. Americas Antacid Revenue 2018-2023 ($ Millions)
    Figure 28. APAC Antacid Sales 2018-2023 (M Units)
    Figure 29. APAC Antacid Revenue 2018-2023 ($ Millions)
    Figure 30. Europe Antacid Sales 2018-2023 (M Units)
    Figure 31. Europe Antacid Revenue 2018-2023 ($ Millions)
    Figure 32. Middle East & Africa Antacid Sales 2018-2023 (M Units)
    Figure 33. Middle East & Africa Antacid Revenue 2018-2023 ($ Millions)
    Figure 34. Americas Antacid Sales Market Share by Country in 2022
    Figure 35. Americas Antacid Revenue Market Share by Country in 2022
    Figure 36. Americas Antacid Sales Market Share by Type (2018-2023)
    Figure 37. Americas Antacid Sales Market Share by Application (2018-2023)
    Figure 38. United States Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 39. Canada Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 40. Mexico Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 41. Brazil Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 42. APAC Antacid Sales Market Share by Region in 2022
    Figure 43. APAC Antacid Revenue Market Share by Regions in 2022
    Figure 44. APAC Antacid Sales Market Share by Type (2018-2023)
    Figure 45. APAC Antacid Sales Market Share by Application (2018-2023)
    Figure 46. China Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 47. Japan Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 48. South Korea Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 49. Southeast Asia Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 50. India Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 51. Australia Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 52. China Taiwan Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 53. Europe Antacid Sales Market Share by Country in 2022
    Figure 54. Europe Antacid Revenue Market Share by Country in 2022
    Figure 55. Europe Antacid Sales Market Share by Type (2018-2023)
    Figure 56. Europe Antacid Sales Market Share by Application (2018-2023)
    Figure 57. Germany Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 58. France Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 59. UK Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 60. Italy Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 61. Russia Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 62. Middle East & Africa Antacid Sales Market Share by Country in 2022
    Figure 63. Middle East & Africa Antacid Revenue Market Share by Country in 2022
    Figure 64. Middle East & Africa Antacid Sales Market Share by Type (2018-2023)
    Figure 65. Middle East & Africa Antacid Sales Market Share by Application (2018-2023)
    Figure 66. Egypt Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 67. South Africa Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 68. Israel Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 69. Turkey Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 70. GCC Country Antacid Revenue Growth 2018-2023 ($ Millions)
    Figure 71. Manufacturing Cost Structure Analysis of Antacid in 2022
    Figure 72. Manufacturing Process Analysis of Antacid
    Figure 73. Industry Chain Structure of Antacid
    Figure 74. Channels of Distribution
    Figure 75. Global Antacid Sales Market Forecast by Region (2024-2029)
    Figure 76. Global Antacid Revenue Market Share Forecast by Region (2024-2029)
    Figure 77. Global Antacid Sales Market Share Forecast by Type (2024-2029)
    Figure 78. Global Antacid Revenue Market Share Forecast by Type (2024-2029)
    Figure 79. Global Antacid Sales Market Share Forecast by Application (2024-2029)
    Figure 80. Global Antacid Revenue Market Share Forecast by Application (2024-2029)

AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter＆Gamble
GlaxoSmithKline
Johnson＆Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Reddy's Laboratories

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape